← Browse by Condition
Medical Condition

pachyonychia congenita

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT05643872 Phase 3
Recruiting

A Study Evaluating the Safety and Pharmacokinetics of QTORIN Rapamycin 3.9% Anhydrous Gel in the Treatment of Adults With Pachyonychia Congenita

Enrollment
45 pts
Location
United States
Sponsor
Palvella Therapeutics, Inc.
View Trial →